Literature DB >> 29245272

Epithelial-myoepithelial carcinoma with high-grade transformation of parotid gland: A case report and literature review.

Bowen Li1, Hongyu Yang, Xia Hong, Yufan Wang, Feng Wang.   

Abstract

RATIONALE: Epithelial-myoepithelial carcinoma (EMC) is regarded as a rare low-grade malignant tumor of the salivary gland, accounting for 0.4% to 1% of all salivary gland tumors. However, epithelial-myoepithelial carcinoma with high-grade transformation (EMC with HGT) is extremely rare, therefore it is easily to be inappropriately diagnosed and treated. Herein, we report an unusual case of EMC with HGT involving the parotid gland and discuss the clinical features and histological characteristic of EMC with HGT, in order to remind the doctors to take appropriate diagnosis and treatment. PATIENT CONCERNS: A 77-year-old female sought for treatment in our hospital due to pain mass in the left parotid gland for 6 months with rapid growth recently. DIAGNOSES: EMC with HGT was confirmed by final pathology, and then the result showed there were 2 distinctly different areas in the tumor, including the typical EMC component and intensive spindle cells component.
INTERVENTIONS: The extensive resection surgery was performed. OUTCOMES: The patient was uneventful after surgery and no recurrence or metastasis has been observed after follow-up of 4 years. LESSONS: A review of literature suggested that EMC with HGT patients trend to be more aged, more aggressive and poorer prognosis than typical EMC patients. In order to avoid misdiagnosis and inappropriate treatment, it is necessary to accurately recognize the differences between the EMC with HGT and typical EMC.

Entities:  

Mesh:

Year:  2017        PMID: 29245272      PMCID: PMC5728887          DOI: 10.1097/MD.0000000000008988

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

Epithelial-myoepithelial carcinoma (EMC) is a rare malignant neoplasm of the salivary gland, accounting for 0.4% to 1% of all salivary gland tumors.[ Typically, the EMC is described as a firm tumor, which is hard to invade to the adjacent tissues. Although it has a high rate of recurrence ranging from 35% to 40%, the mortality is low.[ Therefore, it is considered as a low-grade tumor. Histologically, the EMC generally presents a typical biphasic pattern composing of 2 cell types with variable proportions. The morphology shows the clear myoepithelial cells surround the epithelium-lined ducts, which resemble intercalated ducts in the inner layer.[ However, several new morphologic subtypes of EMC, which includes double clear EMC, oncocytic EMC, sebaceous EMC, apocrine EMC, EMC ex pleomorphic adenoma as well as EMC with high-grade transformation (HGT) have been recognized recently.[ HGT is defined as a histological progression of low-grade tumor to high-grade morphology, where the original histological characteristics are lost.[ The concept of HGT was also known as dedifferentiation previously[ and was first proposed by Dahlin and Beabout in 1971. The HGT components commonly reported to be undifferentiated carcinoma, poorly differentiated adenocarcinoma or high-grade myoepithelial carcinoma,[ so the conventional and high-grade transformation components are distinguishable. Recently, this phenomenon of EMC has been define as the concept of HGT, but EMC with HGT is extremely rare.[ Due to few cases were reported, the clinicopathologic features and treatment of this neoplasm are not yet clear. In this report, we present an interesting case of EMC with HGT located in the left parotid gland. To our knowledge, there are only 21 EMC with HGT cases reported in the literature to date. Patient provided written informed consent.

Case report

A 77-year-old female sought for treatment in our hospital due to pain mass in the left parotid gland. The lesion was symptomatic and had been present about 6 months with a recent rapid increase in size. The patient reported no prior surgeries. Upon examination, there was a 3.5 × 3.0 × 1.5 cm medium texture, unclear boundary, immobile, and pain mass, but the facial nerve function was intact. There was no palpable lymphadenopathy. The remaining oral cavity and head and neck examinations were normality. A large mass sized 35 × 30 × 15 mm in the left parotid gland was identified on MRI (Fat suppressed T2-weighted images showed mild hyperintensity, T1-weighted images showed hyperintensity). The mass was heterogeneous and had an unclear margin, so MRI suggested the mass could be a malignant tumor. At surgery, we remove the tumor to the biopsy, and then the lesion was considered as a malignant neoplasm. The tumor was not invaded to adjacent tissues, so the patient subsequently underwent extensive resection of the tumor with a safety margin of 1 cm under general anesthesia. Then the tumor was sent for histopathological and immunohistochemistry analysis to confirm the histogenetic origin of the lesion. There were 2 different components including typical EMC and high-grade carcinoma in the lesion. The EMC component includes the inner layer of duct consisted of cuboidal epithelial cells and the outer layer consisted of clear myoepithelial cells. They present various tumor cells, which arrange in trabecular, tubular, or islands. The high-grade transformation component was composing of intensive spindle cells with increased nuclear pleomorphism, mitotic activity, prominent nucleolus and acidophilic cytoplasm. The large amount of spindle cells arranged in fascicular clusters (Fig. 1). Immunohistochemical examination indicated that the EMC component was diffusely positive to CK. The tumor cells of the EMC were only positive for CD117 in the duct, and the outer myoepithelial cells were positive for P63, Calponin and S-100 (Fig. 2). However, the high-grade transformation component was all negative for these biomarkers of the typical EMC. The final pathologic diagnosis was the EMC with HGT.
Figure 1

(A) The tumor presents a transition from typical EMC (right) to a high-grade component (left) (HE, 40 × ). (B) The component of typical EMC with inner layer of epithelial cells and an outer clear myoepithelial cell layer (HE, 200×). (C) The HGT component showed intensive spindle cells with increased nuclear pleomorphism, mitotic activity, prominent nucleolus and acidophilic cytoplasm (HE, 200×). EMC = epithelial-myoepithelial carcinoma, HE staining = hematoxylin-eosin staining, HGT = high-grade transformation.

Figure 2

(A) CK was positive in the EMC epithelial component. (B) The CD117 only was positive in the duct of EMC component. (C) Calponin was positive in the EMC myoepithelial component. (D) P63 was positive in the EMC myoepithelial component. (E) S-100 was positive in the EMC myoepithelial component. (magnification, 200×). CK = cytokeratin, EMC = epithelial-myoepithelial carcinoma.

(A) The tumor presents a transition from typical EMC (right) to a high-grade component (left) (HE, 40 × ). (B) The component of typical EMC with inner layer of epithelial cells and an outer clear myoepithelial cell layer (HE, 200×). (C) The HGT component showed intensive spindle cells with increased nuclear pleomorphism, mitotic activity, prominent nucleolus and acidophilic cytoplasm (HE, 200×). EMC = epithelial-myoepithelial carcinoma, HE staining = hematoxylin-eosin staining, HGT = high-grade transformation. (A) CK was positive in the EMC epithelial component. (B) The CD117 only was positive in the duct of EMC component. (C) Calponin was positive in the EMC myoepithelial component. (D) P63 was positive in the EMC myoepithelial component. (E) S-100 was positive in the EMC myoepithelial component. (magnification, 200×). CK = cytokeratin, EMC = epithelial-myoepithelial carcinoma. Adjuvant radiotherapy was suggested, but the patient refused the proposition because of her age. Fortunately, no complications were observed during recovery. The patient was uneventful after surgery and no recurrence or metastasis has been observed after follow-up of 4 years.

Discussion

The EMC with HGT is exceedingly rare. HGT may be considered as a slow process with increasing genomic heterogeneity or as a result of an abrupt transition event. So far, 2 forms of the EMC with HGT have been found. The one form was described as EMC with myoepithelial anaplasia or myoepithelial carcinoma arising in EMC, which was defined as severe nuclear atypia and pleomorphism that occurs gradually in the myoepithelial component.[ The nuclear atypia usually is great than 20% in myoepithelial cells.[ It means a gradual transition of the myoepithelial component of EMC into a more aggressive carcinoma. In the other form, the ductal component can transform into a high-grade carcinoma but the transition is abrupt and rarely. In addition, there is a large amount of nuclear fission and necrosis in the conversion component. In the present case, there were large areas of typical biphasic EMC but the high-grade transformation component was made of intensive spindle cells with increased nuclear pleomorphism, mitotic activity and prominent nucleolus. Moreover, this high-grade component, being tightness adjacent to those low-grade areas, showed negativity for p63, S-100 and calponin. So the authors consider this case is more accord with the form that the EMC abruptly transform the pleomorphic sarcoma. In order to being fully understand the clinicopathological features, treatment modality and prognosis of EMC with HGT, so a literature search was performed. A summary of all 22 cases including our case are presented in Table 1. Overall, we found only 21 cases of the EMC with HGT has been reported. The age of patients’ ranged from 46 to 103 years and the median age of diagnosis was 72 years. The male to female ratio is 7:11. As we known, the typical EMC has a slight female predominance and has occurred in patients between 8 and 103 years with a mean age of about 60 years,[ so I speculated the patients with EMC containing a high-grade transformation component have been older than typical EMC patients. The most frequent site was the parotid gland, followed by the submandibular gland and palate. The lymph node and distant metastases were respectively reached up to 40% and 20%. Only one patient had confirmed mortality. The current patient alive 4 years with no recurrence after surgery. However, the EMC is generally regarded as a low-grade malignancy, the local recurrence rate is estimated to be 30%, and the distant metastases are extremely rare in only 4.5%,[ so the data has been shown to be more aggressive than typical EMC with a high propensity for cervical lymph node and distant metastases. Though the reported cases are limited and follow-up is insufficiency and short, the poor prognosis suggest the patients of EMC with HGT should be necessary with more radical treatment than typical EMC, including wider excision, neck dissection and even adjuvant radiation therapy.[
Table 1

Clinicopathologic summary of 22 cases of EMC with HGT.

Clinicopathologic summary of 22 cases of EMC with HGT. In conclusion, the EMC with HGT is extremely rare and the authors described a rare case of EMC with HGT arising in the parotid gland. According to the analysis, it is more aggressive and worse prognosis, so it is significant to accurately diagnose the EMC with HGT to avoid inappropriate treatment. More studies are needed in order to deeply understand the clinical and histopathologic features of the EMC with HGT.
  19 in total

1.  Epithelial-myoepithelial carcinoma with high grade transformation.

Authors:  Paromita Roy; Martin J Bullock; Bayardo Perez-Ordoñez; Irving Dardick; Ilan Weinreb
Journal:  Am J Surg Pathol       Date:  2010-09       Impact factor: 6.394

2.  Epithelial-myoepithelial carcinoma of salivary glands.

Authors:  R H Simpson; T J Clarke; P T Sarsfield; P G Gluckman
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

3.  Epithelial-Myoepithelial Carcinoma of the Salivary Glands: An Analysis of 246 Cases.

Authors:  Alejandro Vázquez; Tapan D Patel; Christine M D'Aguillo; Rami Y Abdou; William Farver; Soly Baredes; Jean Anderson Eloy; Richard Chan W Park
Journal:  Otolaryngol Head Neck Surg       Date:  2015-07-20       Impact factor: 3.497

4.  Epithelial-myoepithelial carcinoma with myoepithelial anaplasia: report of a case with cytologic findings of a rare variant.

Authors:  Takashi Suzuki; Shin-ichi Murata; Hiroshi Yamaguchi; Yoshihiko Shimizu; Michio Shimizu
Journal:  Acta Cytol       Date:  2010 Jul-Aug       Impact factor: 2.319

Review 5.  Hybrid carcinoma of the parotid gland: report of a case (epithelial-myoepithelial carcinoma and salivary duct carcinoma) and review of the literature.

Authors:  Kazuyuki Kainuma; Aki Oshima; Hiroaki Suzuki; Mana Fukushima; Hisashi Shimojo; Shin-Ichi Usami
Journal:  Acta Otolaryngol       Date:  2010       Impact factor: 1.494

6.  Dedifferentiated epithelial-myoepithelial carcinoma of the parotid gland with aberrant expression of prostate specific antigen: a case report.

Authors:  Venetia R Sarode; John Truelson; Mandolin Zaidie
Journal:  Int J Surg Pathol       Date:  2009-04-29       Impact factor: 1.271

Review 7.  Dedifferentiated epithelial-myoepithelial carcinoma of the parotid gland: a rare case report of immunohistochemical analysis and review of the literature.

Authors:  Kimihide Kusafuka; Yoshinori Takizawa; Takao Ueno; Hiroto Ishiki; Rie Asano; Tomoyuki Kamijo; Yoshiyuki Iida; Mitsuru Ebihara; Yojiro Ota; Tetsuro Onitsuka; Toru Kameya
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-04-16

8.  [Secondary high-malignant transformation of a low-malignant epithelial-myoepithelial carcinoma].

Authors:  M Niederhagen; P Zengel; S Ihrler
Journal:  Pathologe       Date:  2009-11       Impact factor: 1.011

Review 9.  Advances in salivary gland pathology.

Authors:  W Cheuk; J K C Chan
Journal:  Histopathology       Date:  2007-05-31       Impact factor: 5.087

Review 10.  "Dedifferentiation" and high-grade transformation in salivary gland carcinomas.

Authors:  Toshitaka Nagao
Journal:  Head Neck Pathol       Date:  2013-07-03
View more
  3 in total

1.  Metastatic Carcinoma to the Right Heart: The Complementary Utility of Contrast-Enhanced Echocardiography and Cardiac Positron Emission Tomography/Computed Tomography.

Authors:  Lamere Buchanan; Michael Dangl; Asim Syed; Jelani K Grant; Alfred Tanglao; Rhea Sancassani
Journal:  CASE (Phila)       Date:  2021-11-14

2.  Epithelial-myoepithelial carcinoma ex pleomorphic adenoma of the parotid gland with unique histologic differentiation: A rare case report.

Authors:  Doddabasavaiah Basavapur Nandini; Wahengbam Tulsidas Singh; Potsangbam Aparnadevi; Deepak Singh Ningombam
Journal:  J Oral Maxillofac Pathol       Date:  2022-02-28

3.  Epithelial-myoepithelial carcinoma of the parotid gland with primary lung cancer: A rare case report.

Authors:  Huanhuan Wang; Yuyu Zhang; Bin Wang; Jinlong Wei; Rui Ji; Lihua Dong; Xin Jiang
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.